Personnel

Pharmaceutical company appoints new member to corporate advisory board

Published in Cancer Weekly, May 25th, 2004

Provectus Pharmaceuticals, Inc., (PVCT) announced that Paul M. Goldfarb, MD, has been appointed to the company's newly formed corporate advisory board.

Goldfarb is a surgical oncologist who has been in practice for 20 years. He is active in the American Cancer Society and has been president of the California state chapter and served on the national board of directors.

He is currently on the Scientific Review board and Institutional Review board at Scripps Health Care and is a member of the board of Governors for the Scripps Cancer Center.

Craig Dees, PhD, chief executive officer of Provectus, said, "Dr. Goldfarb is a strong...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-05-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry